Data / Form D filings / BIO BLAST PHARMA LTD.
BIO BLAST PHARMA LTD.: Form D filings
BIO BLAST PHARMA LTD., a pharmaceuticals company in New Haven, CT, filed 2 Form D notices with the SEC between 2014 and 2016. The latest, on April 1, 2016, reports $6.7 million sold of a $6.7 million offering to 4 investors.
Find out what BIO BLAST PHARMA LTD. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CONNECTICUT FINANCIAL CENTER, 157 CHURCH STREET (19TH FLOOR), New Haven, CT, 06510
- Phone
- (475) 655-3032
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Year incorporated
- 2012
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1596812
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2016 | New notice | $6,699,999 | $6,699,999 | $0 | 4 | Mar 22, 2016 | sec.gov |
| Feb 13, 2014 | New notice | $4,750,000 | $4,750,000 | $0 | 28 | Feb 6, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Firuta | Executive Officer | |
| Theresa M. Stevens | Executive Officer | |
| Robert Cook | Executive Officer | |
| Dalia I. H. Megiddo | Director | |
| Warren Wasiewski | Executive Officer | |
| Michael M. Burshtine | Director | |
| Leigh M. Cherry | Executive Officer | |
| Fredric Price | Executive Officer, Director | |
| Ran Nusbaum | Director | |
| Thomas I. H. Dubin | Director | |
| Isaac I. H. Krymolowski | Director | |
| Udi Gilboa | Director | |
| Colin Foster | Executive Officer, Director | |
| Gili M. Cohen | Director | |
| Marlene Haffner | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Mar 28, 2016 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BIO BLAST PHARMA LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.